Efficacy and safety of larotrectinib in neurotrophic tyrosine receptor kinase fusion-positive solid tumors: A multicenter retrospective cohort study in Korea

被引：0

作者：

Lee, S. ^{[1
]}

Yoon, S. ^{[2
]}

Choi, W. ^{[3
]}

Jung, H. A. ^{[4
]}

Bae, S. B. ^{[5
]}

Kim, C. G. ^{[6
]}

Kim, H. R. ^{[7
]}

Lee, K-w. ^{[8
,14
]}

Kang, E. J. ^{[9
]}

Shin, K. ^{[10
,11
]}

Lim, D-j. ^{[12
]}

Kim, . s.

Park, S. ^{[13
]}

Lee, K-e.

Lee, Y. ^{[15
]}

Kim, H. S. ^{[16
]}

Kim, T. J. ^{[17
]}

Kim, M. J. ^{[18
]}

Kang, J. H. ^{[19
]}

机构：

[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Med Oncol,Dept Internal Med, Seoul, South Korea

[2] Univ Ulsan, Asan Med Ctr, Oncol Dept, Seoul, South Korea

[3] Ctr Clin Trials, Natl Canc Ctr, NCC, Goyang, South Korea

[4] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr SMC, Div Hematol Oncol,Sch Med, Seoul, South Korea

[5] Soonchunhyang Univ Hosp, Dept Internal Med, Div Hematooncol, Cheonan, South Korea

[6] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea

[7] Yonsei Univ, Med Oncol Dept, Yonsei Canc Ctr, Seoul, South Korea

[8] Seoul Natl Univ, Internal Med Dept, Bundang Hosp, Seongnam, South Korea

[9] Korea Univ, Guro Hosp, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[10] Catholic Univ Korea, Internal Med Dept, Seoul, South Korea

[11] Seoul St Marys Hosp, Catholic Med Ctr, Seoul, South Korea

[12] Catholic Univ Korea, Seoul St Marys Hosp, Endocrinol, Seoul, South Korea

[13] Samsung Med Ctr SMC, Hematol & Med Oncol, Seoul, South Korea

[14] Ewha Womans Univ, Mokdong Hosp, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea

[15] Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea

[16] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[17] Catholic Univ Korea, Dept Hosp Pathol, Yeouido St Marys Hosp, Coll Med, Seoul, South Korea

[18] Catholic Univ Korea, Dept Hosp Pathol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea

[19] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Med Ctr, Med Oncol Dept, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.10.517

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

492P

引用

页数：2

共 50 条

[41] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET
Perreault, Sebastien
Doz, Francois
Drilon, Alexander
Geoerger, Birgit
Boni, Valentina
Chisholm, Julia
Dubois, Steven G.
Grilley-Olson, Juneko E.
Hong, David S.
Italiano, Antoine
Kang, HyoungJin
Nysom, Karsten
Ora, Ingrid
Owens, Cormac
Schulte, Johannes H.
Tahara, Makoto
Ziegler, David
Ellezam, Benjamin
Reeves, John A.
Fellous, Marc
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2020, 22 : 58 - 58
[42] Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.
Drilon, Alexander E.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Patel, Jyoti D.
Lassen, Ulrik Niels
Leyvraz, Serge
Moreno, Victor
Rosen, Lee S.
Solomon, Benjamin Maurice
Yachnin, Jeffrey
Liu, Yongmei
Dai, Ming-Shen
Norenberg, Ricarda
Fellous, Marc Mardoche
Mussi, Chiara Erminia
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[43] Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
Drilon, A.
Shen, L.
van Tilburg, C.
Doz, F.
Tan, D. S. W.
Lin, J. J.
Kummar, S.
Lassen, U. N.
McDermott, R. S.
Dierselhuis, M. P.
Albert, C. M.
Nagasubramanian, R.
Watt, T.
Patil, T.
Burcoveanu, D-I.
Norenberg, R.
Brega, N.
Laetsch, T. W.
Xu, R-H.
Hong, D. S.
ANNALS OF ONCOLOGY, 2023, 34 : S470 - S470
[44] Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers
Rotow, Julia
Patel, Jyoti D.
Hanley, Matthew P.
Yu, Helena
Awad, Mark
Goldman, Jonathan W.
Nechushtan, Hovav
Schef, Matthias
Kuo, Chih-Hsi S.
Rajappa, Senthil
Harada, Guilherme
Clifford, Sarah
Santucci, Alison
Silva, Laura
Tupper, Rebecca
Oxnard, Geoffrey R.
Kherani, Jennifer
Drilon, Alexander
CLINICAL CANCER RESEARCH, 2023, 29 (16) : 2979 - 2987
[45] Improving Outcomes in Pediatric NTRK Gene Fusion-Positive Solid Tumors: Importance of Genomic Testing and Targeted Therapy With the TRK Inhibitor Larotrectinib
Laetsch, Theodore W.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (04)
[46] Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved for the Treatment of Pediatric and Adult Patients with NTRK Fusion-positive, Recurrent or Advanced Solid Tumors
Osman, Hind M.
Tuncbilek, Meral
CURRENT MEDICINAL CHEMISTRY, 2022, 29 (15) : 2602 - 2616
[47] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Perreault, Sebastien
Drilon, Alexander
Lassen, Ulrik N.
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Gavrilovic, Igor T.
Norenberg, Ricarda
Bernard-Gauthier, Vadim
De la Cuesta, Esther
Laetsch, Theodore W.
Doz, Francois
Van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2022, 24 : 87 - 87
[48] Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors (vol 28, pg 1302, 2022)
Demetri, George D.
De Braud, Filippo
Drilon, Alexander
Siena, Salvatore
Patel, Manish R.
Cho, Byoung Chul
Liu, Stephen, V
Ahn, Myung-Ju
Chiu, Chao-Hua
Lin, Jessica J.
Goto, Koichi
Lee, Jeeyun
Bazhenova, Lyudmila
John, Thomas
Fakih, Marwan
Chawla, Sant P.
Dziadziuszko, Rafal
Seto, Takashi
Heinzmann, Sebastian
Pitcher, Bethany
Chen, David
Wilson, Timothy R.
Rolfo, Christian
CLINICAL CANCER RESEARCH, 2022, 28 (10) : 2196 - 2196
[49] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Kummar, Shivaani
Patel, Jyoti D.
Cermignani, Luciano
Dai, Ming-Shen
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Rosen, Lee S.
Saada-Bouzid, Esma
Solomon, Benjamin Maurice
Xu, Rui-Hua
Yachnin, Jeffrey
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Mussi, Chiara E.
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[50] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Rieke, D. T.
Lin, Iyeong J.
Tan, D. S.
Kummar, S.
Patel, J. D.
Cermignani, L.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Moreno, V.
Rosen, L.
Saada-Bouzid, E.
Solomon, B.
Xu, R. -H.
Yachnin, J.
Norenberg, R.
Burcoveanu, D. -I.
Mussi, C. E.
Shen, L.
Drilon, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 9 - 10

← 1 2 3 4 5 →